- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.07. | Lilly Acquires Verve Therapeutics | ||
| 28.07. | ReAlta Life Sciences Names Ellen Lubman as Chief Business Officer | ||
| 28.07. | MAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine | ||
| 28.07. | AstraZeneca's sBLA for IMFINZI Accepted and Granted Priority Review | ||
| 25.07. | Simtra Purchases 65-Acre Property in Indiana | ||
| 25.07. | Sanofi's Sarclisa Gains EU Approval for Multiple Myeloma | ||
| 25.07. | Bristol Myers Squibb Names New EVP, Chief Medical Officer and Head of Development | ||
| 24.07. | Matchpoint Therapeutics, Novartis Partner to Develop Covalent Medicines for Inflammatory Diseases | ||
| 24.07. | Verastem Oncology's VS-7375 Granted Fast Track Designation by the FDA | ||
| 24.07. | Pfizer Bolsters Oncology Pipeline with $1.25B 3SBio Deal | ||
| 23.07. | Stevanato Group Secures $235.4 Million in Financing | ||
| 23.07. | Sygnature Discovery Doubles High-Throughput Chemistry Capacity After Investment | ||
| 23.07. | Crown Bioscience's San Diego Lab Receives CLIA Certification | ||
| 23.07. | Roquette Launches POLYOX Extended Stability Packaging | ||
| 23.07. | Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD | ||
| 23.07. | Ipsen Updates Executive Committee | ||
| 22.07. | Upsher-Smith Hosts Iowa Governor for Roundtable Discussion & Facility Tour | ||
| 22.07. | Solvias Center of Excellence for Biologics & Novel Modalities Becomes cGMP Ready | ||
| 22.07. | Coriolis Pharma Opens New Laboratory in Morrisville, NC | ||
| 22.07. | Abzena Appoints Geoffrey Glass as CEO | ||
| 22.07. | AstraZeneca to Invest $50 Billion in the U.S. by 2030 | ||
| 21.07. | Merck Adopts Veeva Vault CRM | ||
| 21.07. | Cycle Pharmaceuticals Selects LeMed as Exclusive U.S. Distribution & Services Partner for HARLIKU | ||
| 21.07. | Bizerba Joins Körber's PAS-X Weigh & Dispense Technology Partner Program | ||
| 21.07. | Sanner Opens First U.S.-Based Production Facility in Greensboro, NC |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .